CTNM

Neutral

Contineum Therapeutics CSO Daniel Lorrain sells $594,578 in stock By Investing.com

Daniel S. Lorrain, Chief Scientific Officer of Contineum Therapeutics, Inc. (NASDAQ:CTNM), sold approximately $594,578 worth of Class A Common Stock a...

Investing.com India 22 mins ago 0

Bearish

Contineum (NASDAQ: CTNM) CSO sells 37,179 shares and exercises 33,009 options

Contineum Therapeutics' Chief Scientific Officer, Daniel S. Lorrain, recently sold 37,179 shares of Class A Common Stock and exercised options for 33,...

Stock Titan 22 mins ago 0